Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Acute metabolic effects of melatonin - a randomized crossover study in healthy young men

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Melatonin: an ancient molecule that makes oxygen metabolically tolerable

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Utility of melatonin to treat surgical stress after major vascular surgery--a safety study.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. A diet-induced gut microbiota component and related plasma metabolites are associated with depressive-like behaviour in rats

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Genome-wide association study of circulating levels of glucagon during an oral glucose tolerance test

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Obesity treatment effect in Danish children and adolescents carrying Melanocortin-4 Receptor mutations

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Successful Use of a GLP-1 Receptor Agonist as Add-on Therapy to Sulfonylurea in the Treatment of KCNJ11 Neonatal Diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Ulla Kampmann
  • Esben S Lauritzen
  • Niels Grarup
  • Niels Jessen
  • Torben Hansen
  • Niels Møller
  • Julie Støy
Vis graf over relationer

Melatonin regulates circadian rhythm, but may also have effects on glucose homeostasis. A common G-allele in the MTNR1B locus has been associated with an increased risk of type 2 diabetes (T2DM). We aimed to examine acute effects of high doses of melatonin on glucose metabolism with attention to MTNR1B genotype. Twenty men were examined in a double-blinded, randomized crossover study on two nonconsecutive days with four doses of 10 mg oral melatonin or placebo. Insulin sensitivity and insulin secretion were assessed by an intravenous glucose tolerance test (IVGTT) and a hyperinsulinaemic-euglycaemic clamp (HEC). Blood samples were drawn to determine the metabolic profile and MTNR1B rs10830963 genotype. Indirect calorimetry and blood pressure measurements were also performed. Insulin sensitivity index was significantly reduced on the melatonin day (P = .028) in the whole group and in homozygous carriers of the rs10830963 C-allele (P = .041). Glucose during the IVGTT was unaffected, but there was a tendency towards lower insulin and C-peptide levels in the first minutes after glucose administration in G-allele carriers. Systolic blood pressure decreased and lipid oxidation increased significantly on the melatonin day in rs10830963 G-allele carriers. Overall, our study reports that acute administration of melatonin in supra-physiological doses may have a negative impact on insulin sensitivity. Clinical trial registration number (clinicaltrial.gov): NCT03204877.

OriginalsprogEngelsk
TidsskriftJournal of Pineal Research
Sider (fra-til)e12706
ISSN0742-3098
DOI
StatusUdgivet - mar. 2021
Eksternt udgivetJa

ID: 61374540